- Home
- INTA vs ZLAB Comparison
INTA vs ZLAB Comparison
Compare INTA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTA
- ZLAB
- Stock Information
- Founded
- INTA 2000
- ZLAB 2013
- Country
- INTA United States
- ZLAB China
- Employees
- INTA N/A
- ZLAB N/A
- Industry
- INTA Computer Software: Prepackaged Software
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- INTA Technology
- ZLAB Health Care
- Exchange
- INTA Nasdaq
- ZLAB Nasdaq
- Market Cap
- INTA 3.5B
- ZLAB 3.2B
- IPO Year
- INTA 2021
- ZLAB 2017
- Fundamental
- Price
- INTA $41.55
- ZLAB $20.98
- Analyst Decision
- INTA Buy
- ZLAB Buy
- Analyst Count
- INTA 9
- ZLAB 6
- Target Price
- INTA $59.63
- ZLAB $57.22
- AVG Volume (30 Days)
- INTA 732.5K
- ZLAB 899.6K
- Earning Date
- INTA 11-04-2025
- ZLAB 11-06-2025
- Dividend Yield
- INTA N/A
- ZLAB N/A
- EPS Growth
- INTA N/A
- ZLAB N/A
- EPS
- INTA N/A
- ZLAB N/A
- Revenue
- INTA $524,342,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- INTA $15.18
- ZLAB $40.71
- Revenue Next Year
- INTA $13.48
- ZLAB $50.42
- P/E Ratio
- INTA N/A
- ZLAB N/A
- Revenue Growth
- INTA 17.11
- ZLAB 24.14
- 52 Week Low
- INTA $35.51
- ZLAB $20.61
- 52 Week High
- INTA $77.74
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- INTA 56.20
- ZLAB 21.54
- Support Level
- INTA $41.16
- ZLAB $21.59
- Resistance Level
- INTA $43.62
- ZLAB $22.28
- Average True Range (ATR)
- INTA 1.66
- ZLAB 0.86
- MACD
- INTA 0.53
- ZLAB -0.18
- Stochastic Oscillator
- INTA 72.70
- ZLAB 6.41
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.